Annual Retained Earnings
-$63.91 M
-$4.51 M-7.59%
December 31, 2023
Summary
- As of February 7, 2025, SBFM annual retained earnings is -$63.91 million, with the most recent change of -$4.51 million (-7.59%) on December 31, 2023.
- During the last 3 years, SBFM annual retained earnings has fallen by -$43.69 million (-216.07%).
- SBFM annual retained earnings is now -487729.77% below its all-time high of -$13.10 thousand, reached on July 1, 2007.
Performance
SBFM Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$66.88 M
-$1.20 M-1.82%
September 30, 2024
Summary
- As of February 7, 2025, SBFM quarterly retained earnings is -$66.88 million, with the most recent change of -$1.20 million (-1.82%) on September 30, 2024.
- Over the past year, SBFM quarterly retained earnings has dropped by -$4.23 million (-6.74%).
- SBFM quarterly retained earnings is now -305295.43% below its all-time high of -$21.90 thousand, reached on October 1, 2007.
Performance
SBFM Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
SBFM Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -7.6% | -6.7% |
| 3 y3 years | -216.1% | -7.9% |
| 5 y5 years | -305.1% | -7.9% |
SBFM Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -95.7% | at low | -104.8% | at low |
| 5 y | 5-year | -266.6% | at low | -283.6% | at low |
| alltime | all time | <-9999.0% | at low | <-9999.0% | at low |
Sunshine Biopharma Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$66.88 M(+1.8%) |
| Jun 2024 | - | -$65.68 M(+0.8%) |
| Mar 2024 | - | -$65.19 M(+2.0%) |
| Dec 2023 | -$63.91 M(+7.6%) | -$63.91 M(+2.0%) |
| Sep 2023 | - | -$62.66 M(+1.1%) |
| Jun 2023 | - | -$62.00 M(+1.5%) |
| Mar 2023 | - | -$61.10 M(+2.9%) |
| Dec 2022 | -$59.40 M(+81.9%) | -$59.40 M(+65.5%) |
| Sep 2022 | - | -$35.89 M(+4.2%) |
| Jun 2022 | - | -$34.43 M(+1.6%) |
| Mar 2022 | - | -$33.89 M(+3.8%) |
| Dec 2021 | -$32.66 M(+61.5%) | - |
| Dec 2021 | - | -$32.66 M(-2.0%) |
| Sep 2021 | - | -$33.32 M(+13.8%) |
| Jun 2021 | - | -$29.28 M(+10.9%) |
| Mar 2021 | - | -$26.40 M(+30.6%) |
| Dec 2020 | -$20.22 M(+16.0%) | -$20.22 M(+5.7%) |
| Sep 2020 | - | -$19.13 M(+5.3%) |
| Jun 2020 | - | -$18.17 M(+3.6%) |
| Mar 2020 | - | -$17.53 M(+0.5%) |
| Dec 2019 | -$17.43 M(+10.5%) | -$17.43 M(+2.3%) |
| Sep 2019 | - | -$17.04 M(+2.1%) |
| Jun 2019 | - | -$16.69 M(+4.4%) |
| Mar 2019 | - | -$15.98 M(+1.3%) |
| Dec 2018 | -$15.77 M(+15.8%) | -$15.77 M(+2.2%) |
| Sep 2018 | - | -$15.44 M(+6.2%) |
| Jun 2018 | - | -$14.53 M(+4.6%) |
| Mar 2018 | - | -$13.88 M(+2.0%) |
| Dec 2017 | -$13.62 M(+8.3%) | -$13.62 M(+1.6%) |
| Sep 2017 | - | -$13.41 M(+1.1%) |
| Jun 2017 | - | -$13.26 M(+3.8%) |
| Mar 2017 | - | -$12.77 M(+1.6%) |
| Dec 2016 | -$12.58 M | -$12.58 M(+9.8%) |
| Sep 2016 | - | -$11.45 M(+16.1%) |
| Jun 2016 | - | -$9.87 M(+5.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2016 | - | -$9.39 M(+3.4%) |
| Dec 2015 | -$9.08 M(+22.3%) | -$9.08 M(+7.7%) |
| Sep 2015 | - | -$8.43 M(+2.3%) |
| Jun 2015 | - | -$8.24 M(+6.7%) |
| Mar 2015 | - | -$7.72 M(+4.0%) |
| Dec 2014 | -$7.43 M(+35.2%) | -$7.43 M(+4.7%) |
| Sep 2014 | - | -$7.09 M(+4.1%) |
| Jun 2014 | - | -$6.81 M(+13.7%) |
| Mar 2014 | - | -$6.00 M(+9.1%) |
| Dec 2013 | -$5.49 M(+83.0%) | -$5.49 M(+14.3%) |
| Sep 2013 | - | -$4.81 M(+3.8%) |
| Jun 2013 | - | -$4.63 M(+3.4%) |
| Mar 2013 | - | -$4.48 M(+49.2%) |
| Dec 2012 | -$3.00 M(+30.9%) | -$3.00 M(+6.7%) |
| Sep 2012 | - | -$2.81 M(+15.5%) |
| Jun 2012 | - | -$2.44 M(+4.4%) |
| Mar 2012 | - | -$2.33 M(+1.7%) |
| Dec 2011 | -$2.29 M(+32.0%) | -$2.29 M(+19.3%) |
| Sep 2011 | - | -$1.92 M(+6.6%) |
| Jun 2011 | - | -$1.80 M(+0.9%) |
| Mar 2011 | - | -$1.79 M(+2.8%) |
| Dec 2010 | -$1.74 M(+44.7%) | -$1.74 M(+27.7%) |
| Sep 2010 | - | -$1.36 M(-52.6%) |
| Jun 2010 | - | -$2.87 M(+123.5%) |
| Mar 2010 | - | -$1.29 M(+13.5%) |
| Dec 2009 | -$1.20 M(+1635.7%) | - |
| Oct 2009 | - | -$1.13 M(+1537.4%) |
| Jul 2009 | -$69.20 K(+56.6%) | -$69.20 K(+14.4%) |
| Apr 2009 | - | -$60.50 K(+10.8%) |
| Jan 2009 | - | -$54.60 K(+7.5%) |
| Oct 2008 | - | -$50.80 K(+14.9%) |
| Jul 2008 | -$44.20 K(+237.4%) | -$44.20 K(+14.5%) |
| Apr 2008 | - | -$38.60 K(+59.5%) |
| Jan 2008 | - | -$24.20 K(+10.5%) |
| Oct 2007 | - | -$21.90 K |
| Jul 2007 | -$13.10 K | - |
FAQ
- What is Sunshine Biopharma annual retained earnings?
- What is the all time high annual retained earnings for Sunshine Biopharma?
- What is Sunshine Biopharma annual retained earnings year-on-year change?
- What is Sunshine Biopharma quarterly retained earnings?
- What is the all time high quarterly retained earnings for Sunshine Biopharma?
- What is Sunshine Biopharma quarterly retained earnings year-on-year change?
What is Sunshine Biopharma annual retained earnings?
The current annual retained earnings of SBFM is -$63.91 M
What is the all time high annual retained earnings for Sunshine Biopharma?
Sunshine Biopharma all-time high annual retained earnings is -$13.10 K
What is Sunshine Biopharma annual retained earnings year-on-year change?
Over the past year, SBFM annual retained earnings has changed by -$4.51 M (-7.59%)
What is Sunshine Biopharma quarterly retained earnings?
The current quarterly retained earnings of SBFM is -$66.88 M
What is the all time high quarterly retained earnings for Sunshine Biopharma?
Sunshine Biopharma all-time high quarterly retained earnings is -$21.90 K
What is Sunshine Biopharma quarterly retained earnings year-on-year change?
Over the past year, SBFM quarterly retained earnings has changed by -$4.23 M (-6.74%)